ArticleAJOG global reports2026
Initial recruitment, diagnosis, conservative management, maternal and perinatal outcomes of hypertensive disorders of pregnancy.
Article in AJOG global reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hypertensive disorders of pregnancy (HDP) constitute a group of conditions characterized by elevation of blood pressure detected for the first time after 20 weeks of gestation, with a global prevalence estimated at nearly 10% of all pregnant women. Objective: To evaluate the clinical evolution and perinatal outcomes of pregnant women identified with a first elevation of blood pressure after 20 weeks of gestation, from the diagnostic confirmation of the type of HDP, until the termination of pregnancy under conservative management in the hospital. Methodology: Observational analytical cohort study in pregnant women attended at the Social Security Fund hospital of Panama, from July 1, 2023, to December 31, 2024. Pregnant women ≥20 weeks of gestation were included, identified for presenting a first elevation of blood pressure (140/90 mmHg), who were subsequently confirmed with an HDP diagnosis through a second elevated blood pressure measurement found in a minimum of 4 hours or a maximum of 7 days. Results: During the 18 months of the study, 191 pregnant women were admitted to confirm or rule out HDP. It was confirmed that 20 (10.4%) had white coat hypertension, in 11 (5.8%), chronic hypertension without superimposed preeclampsia was diagnosed, confirming pregnancy-associated hypertensive disorder in 160 (83.8%). 51.2% with a diagnosis of HDP without severity criteria under conservative management developed severity criteria. The pregnancy prolongation time with conservative management was 3 weeks. The average gestational age at the time of termination was 35 weeks, and 30% of the newborns were admitted to the intensive care unit. There were 8 (5%) perinatal deaths: one in utero and 7 neonatal deaths associated with prematurity. Conclusion: This study shows that one in 10 patients with an initial elevation in blood pressure ultimately has a diagnosis of white-coat hypertension, and that nearly half of pregnant women identified with a first elevation in blood pressure after 20 weeks of gestation develop severe features during conservative inpatient management. HDP are dynamic and evolving entities that may progress unpredictably, leading to high rates of prematurity and maternal and perinatal complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.